A
Clinical-stage drug developer with two candidates: forvisirvat (SP-624), a SIRT6 activator in Phase 2b/3 for major depressive disorder, and RABI-767 for predicted severe acute pancreatitis.
At a glance
- Founded: 2016
- HQ: Morrisville
- Sector: Biotech
- Stage: Series B
- Total raised: $94.3M
Listed roles
All Triangle rolesChecking listed roles…
The rest of this record is behind a free account.
Founders, funding history, investor connections, and recent signals load on this page as soon as you sign in. Accounts open immediately.